Interleukin-6 Receptor Inhibition in Covid-19-Cooling the Inflammatory Soup

被引：99
|
作者：
Rubin, Eric J.
Longo, Dan L.
Baden, Lindsey R.
机构：
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2021年 / 384卷 / 16期
关键词：
PNEUMOCYSTIS-CARINII PNEUMONIA; CORTICOSTEROIDS; TOCILIZUMAB;
D O I：
10.1056/NEJMe2103108
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1564 / 1565
页数：2
相关论文
共 50 条
  • [21] Preventing atrial fibrillation in COVID-19: exploring the role of interleukin-6 receptor antagonists
    Kow, Chia Siang
    Ramachandram, Dinesh Sangarran
    Hasan, Syed Shahzad
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2023, 21 (10) : 713 - 714
  • [22] Severe COVID-19 and interleukin-6 receptor antagonist tocilizumab: Some notes of concern
    Akinosoglou, Karolina
    Gogos, Charalambos
    RESPIROLOGY, 2020, 25 (11)
  • [23] Interleukin-6 receptor blockade in patients with COVID-19: placing clinical trials into context
    Angriman, Federico
    Ferreyro, Bruno L.
    Burry, Lisa
    Fan, Eddy
    Ferguson, Niall D.
    Husain, Shahid
    Keshavjee, Shaf H.
    Lupia, Enrico
    Munshi, Laveena
    Renzi, Samuele
    Ubaldo, Onion Gerald, V
    Rochwerg, Bram
    Del Sorbo, Lorenzo
    LANCET RESPIRATORY MEDICINE, 2021, 9 (06): : 655 - 664
  • [24] Preemptive interleukin-6 blockade in patients with COVID-19
    Lucía Guillén
    Sergio Padilla
    Marta Fernández
    Vanesa Agulló
    José Alberto García
    Guillermo Telenti
    Javier García-Abellán
    Ángela Botella
    Félix Gutiérrez
    Mar Masiá
    Scientific Reports, 10
  • [25] Assessing the importance of interleukin-6 in COVID-19 Reply
    Leisman, Daniel E.
    Ronner, Lukas
    Pinotti, Rachel
    Taylor, Matthew D.
    Sinha, Pratik
    Calfee, Carolyn S.
    Hirayama, Alexandre V.
    Mastroianni, Fiore
    Turtle, Cameron J.
    Harhay, Michael O.
    Legrand, Matthieu
    Deutschman, Clifford S.
    LANCET RESPIRATORY MEDICINE, 2021, 9 (02): : E14 - E15
  • [26] ALDOSTERONE AND INTERLEUKIN-6: IS IT A NEW ASSOCIATION IN COVID-19?
    Campana, P.
    Ranieri, A.
    Basile, C.
    Forzano, I.
    Perillo, E.
    Ciaramella, L.
    Follero, P.
    Tagliamonte, G.
    Sibilio, G.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2022, 24 (SUPPL C)
  • [27] Interleukin-6 as a potential biomarker of COVID-19 progression
    Ulhaq, Zulvikar Syambani
    Soraya, Gita Vita
    MEDECINE ET MALADIES INFECTIEUSES, 2020, 50 (04): : 382 - 383
  • [28] Interleukin-6 Perpetrator of the COVID-19 Cytokine Storm
    Jyoti Shekhawat
    Kavya Gauba
    Shruti Gupta
    Purvi Purohit
    Prasenjit Mitra
    Mahendra Garg
    Sanjeev Misra
    Praveen Sharma
    Mithu Banerjee
    Indian Journal of Clinical Biochemistry, 2021, 36 : 440 - 450
  • [29] Rethinking interleukin-6 blockade for treatment of COVID-19
    Scherger, S.
    Henao-Martinez, A.
    Franco-Paredes, C.
    Shapiro, L.
    MEDICAL HYPOTHESES, 2020, 144
  • [30] Aldosterone and interleukin-6: the synergic effect in COVID-19
    Campana, Pasquale
    Palaia, Maria Emiliana
    Conte, Maddalena
    Petraglia, Laura
    Ferrante, Lorenzo
    Dario, Leosco
    Parisi, Valentina
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (0G)
12345